Virtual Library

Start Your Search

Filter Results:

Show Only Available Presentations

  • +

    P01 - Early Stage/Localized Disease/Ablative Therapies - Adjuvant Therapy

    • Type: Posters
    • Track: Early Stage/Localized Disease/Ablative Therapies
    • Presentations: 2
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      P01.01 - LIBRETTO-432: A Placebo-Controlled Phase 3 Study of Adjuvant Selpercatinib in Stage IB-IIIA RET Fusion-Positive NSCLC

      00:00 - 00:00  |  Presenter: Jonathan Goldman

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P53 - Novel Therapeutics and Targeted Therapies - Others

    • Type: Posters
    • Track: Novel Therapeutics and Targeted Therapies
    • Presentations: 8
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      P53.02 - Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase (TRK) Fusion-Positive Lung Cancer

      00:00 - 00:00  |  Presenter: Alexander Drilon

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    IS10 - Satellite CME Symposium by Research To Practice: Expert Second Opinion: Investigators Discuss Available Clinical Research in the Care of Patients with Non-Small Cell Lung Cancer and Validated Targets Beyond EGFR

    • Type: Satellite CME Symposia
    • Track: N.A.
    • Presentations: 4
    • Moderators:D. Ross Camidge
    • Coordinates: 9/10/2021, 05:45 - 06:45, Program Auditorium
    • +

      IS10.01 - MODULE 1: Selection and Sequencing of Therapy for Patients with Non-Small Cell Lung Cancer (NSCLC) and an ALK Rearrangement

      05:45 - 06:00

      • Abstract

      No abstract available for this presentation

    • +

      IS10.02 - MODULE 2: Current and Future Directions in the Management of ROS1-Positive NSCLC

      06:00 - 06:15

      • Abstract

      No abstract available for this presentation

    • +

      IS10.03 - MODULE 3: Optimal Use of Recently Approved RET Inhibitors in the Care of Patients with RET-Positive NSCLC

      06:15 - 06:30

      • Abstract

      No abstract available for this presentation

    • +

      IS10.04 - MODULE 4: Rational Approaches to Targeting MET Abnormalities for Patients with NSCLC

      06:30 - 06:45

      • Abstract

      No abstract available for this presentation

  • +

    OA17 - Multidisciplinary Care of Thoracic Oncology Patients During COVID-19 Pandemic

    • Type: Oral
    • Track: Nursing and Allied Health Professionals
    • Presentations: 6